Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Y Chang

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
The Lancet. Rheumatology|March 23, 2021
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trialPaul C Cremer, Antonio Abbate, Kristin Hudock, et al.
JAMA|May 19, 2024
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical TrialLorraine B Ware, D Clark Files, Alpha Fowler, et al.
American Journal of Respiratory and Critical Care Medicine|August 31, 2010
Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort studyOgnjen Gajic, Ousama Dabbagh, Pauline K Park, et al.
JAMA Network Open|February 14, 2023
Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 MonthsAndrew J Admon, Theodore J Iwashyna, Lee A Kamphuis, et al.
Critical Care Medicine|October 23, 2013
Structure, process, and annual ICU mortality across 69 centers: United States Critical Illness and Injury Trials Group Critical Illness Outcomes StudyWilliam Checkley, Greg S Martin, Samuel M Brown, et al.
Critical Care Medicine|June 26, 2015
Protocols and Hospital Mortality in Critically Ill Patients: The United States Critical Illness and Injury Trials Group Critical Illness Outcomes StudyJonathan E Sevransky, William Checkley, Phabiola Herrera, et al.
Chest|November 18, 2023
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of LifeYonatan Y Greenstein, Kinsley Hubel, Joshua Froess, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|October 28, 2021
Characteristics and Outcomes of US Patients Hospitalized With COVID-19Ithan D Peltan, Ellen Caldwell, Andrew J Admon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2021
Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and OutcomesSamira Sami, Mark W Tenforde, H Keipp Talbot, et al.
CHEST Critical Care|January 23, 2026
Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis: The Phase 2b ASTER TrialD Clark Files, Michael A Matthay, Lorraine B Ware, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
The Lancet. Rheumatology|March 23, 2021
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trialPaul C Cremer, Antonio Abbate, Kristin Hudock, et al.
JAMA|May 19, 2024
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical TrialLorraine B Ware, D Clark Files, Alpha Fowler, et al.
American Journal of Respiratory and Critical Care Medicine|August 31, 2010
Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort studyOgnjen Gajic, Ousama Dabbagh, Pauline K Park, et al.
JAMA Network Open|February 14, 2023
Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 MonthsAndrew J Admon, Theodore J Iwashyna, Lee A Kamphuis, et al.
Critical Care Medicine|October 23, 2013
Structure, process, and annual ICU mortality across 69 centers: United States Critical Illness and Injury Trials Group Critical Illness Outcomes StudyWilliam Checkley, Greg S Martin, Samuel M Brown, et al.
Critical Care Medicine|June 26, 2015
Protocols and Hospital Mortality in Critically Ill Patients: The United States Critical Illness and Injury Trials Group Critical Illness Outcomes StudyJonathan E Sevransky, William Checkley, Phabiola Herrera, et al.
Chest|November 18, 2023
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of LifeYonatan Y Greenstein, Kinsley Hubel, Joshua Froess, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|October 28, 2021
Characteristics and Outcomes of US Patients Hospitalized With COVID-19Ithan D Peltan, Ellen Caldwell, Andrew J Admon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2021
Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and OutcomesSamira Sami, Mark W Tenforde, H Keipp Talbot, et al.
CHEST Critical Care|January 23, 2026
Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis: The Phase 2b ASTER TrialD Clark Files, Michael A Matthay, Lorraine B Ware, et al.
Pageof 8